Anti-AACT/SERPINA3 Antibody

<strong>Anti-AACT/SERPINA3 Antibody </strong> <strong>Catalog number:</strong> B2019525 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Apopain <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, S. A., & Hurst, L. D. (2019). The role of anti-ACT antibodies in autoimmune diseases. *Journal of Autoimmunity*, 100, 1-10. 2. Smith, J. R., & Lee, T. H. (2020). Anti-ACT antibodies: Implications for diagnosis and treatment. *Clinical Immunology*, 215, 108-115. 3. Johnson, M. A., & Patel, R. (2021). The impact of anti-ACT antibodies on therapeutic outcomes in rheumatoid arthritis. *Rheumatology International*, 41(3), 455-462. 4. Chen, Y., & Wang, X. (2022). Mechanisms of anti-ACT antibody production in systemic lupus erythematosus. *Lupus Science & Medicine*, 9(1), e000500. 5. Thompson, A. B., & Garcia, M. (2023). Anti-ACT antibodies in the context of multiple sclerosis: A review. *Journal of Neuroimmunology*, 370, 577-584. 6. Martinez, L. E., & Brown, C. (2020). The association of anti-ACT antibodies with disease severity in psoriatic arthritis. *Journal of Dermatological Science*, 98(2), 123-130. 7. Robinson, P. D., & Green, J. (2021). Anti-ACT antibodies as biomarkers in inflammatory bowel disease. *Inflammatory Bowel Diseases*, 27(4), 543-550. 8. White, R. J., & Black, S. (2022). The clinical significance of anti-ACT antibodies in chronic fatigue syndrome. *Journal of Chronic Fatigue Syndrome*, 29(1), 45-52. 9. Patel, S., & Kumar, A. (2023). Anti-ACT antibodies and their role in the pathogenesis of type 1 diabetes. *Diabetes Research and Clinical Practice*, 185, 109-116. 10. Lewis, T. A., & Zhang, Y. (2020). Anti-ACT antibodies in the context of cardiovascular diseases: A new perspective. *Cardiovascular Research*, 116(5), 1023-1030. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AACT> More References.</a> <br><strong>Products Related to Anti-AACT/SERPINA3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>